A detailed history of Sheets Smith Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Sheets Smith Wealth Management holds 8,794 shares of LLY stock, worth $8.12 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
8,794
Previous 2,253 290.32%
Holding current value
$8.12 Million
Previous $1.75 Million 354.39%
% of portfolio
0.96%
Previous 0.2%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $4.74 Million - $5.95 Million
6,541 Added 290.32%
8,794 $7.96 Million
Q1 2024

May 08, 2024

SELL
$592.2 - $792.28 $20,134 - $26,937
-34 Reduced 1.49%
2,253 $1.75 Million
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $2,625 - $3,095
5 Added 0.22%
2,287 $1.33 Million
Q3 2023

Oct 23, 2023

BUY
$434.7 - $599.3 $434 - $599
1 Added 0.04%
2,282 $1.23 Million
Q2 2023

Aug 09, 2023

SELL
$350.74 - $468.98 $12,626 - $16,883
-36 Reduced 1.55%
2,281 $1.07 Million
Q1 2023

May 26, 2023

BUY
$310.63 - $364.82 $613,183 - $720,154
1,974 Added 575.51%
2,317 $795,000
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $610,077 - $716,506
-1,964 Reduced 85.13%
343 $117,000
Q4 2022

Mar 08, 2023

SELL
$321.55 - $374.67 $38,586 - $44,960
-120 Reduced 4.94%
2,307 $843,000
Q3 2022

Nov 01, 2022

BUY
$296.48 - $337.87 $3,261 - $3,716
11 Added 0.46%
2,427 $785,000
Q2 2022

Jul 27, 2022

BUY
$278.73 - $327.27 $4,180 - $4,909
15 Added 0.62%
2,416 $783,000
Q1 2022

May 02, 2022

BUY
$234.69 - $291.66 $469 - $583
2 Added 0.08%
2,401 $688,000
Q4 2021

Jan 20, 2022

BUY
$224.85 - $279.04 $224 - $279
1 Added 0.04%
2,399 $663,000
Q2 2021

Aug 03, 2021

BUY
$180.55 - $233.54 $180 - $233
1 Added 0.04%
2,398 $550,000
Q1 2021

Apr 23, 2021

SELL
$164.32 - $212.72 $18,075 - $23,399
-110 Reduced 4.39%
2,397 $448,000
Q4 2020

Jan 13, 2021

SELL
$130.46 - $172.63 $433,909 - $574,167
-3,326 Reduced 57.02%
2,507 $423,000
Q3 2020

Oct 26, 2020

BUY
$146.22 - $169.13 $486,473 - $562,695
3,327 Added 132.76%
5,833 $863,000
Q2 2020

Jul 17, 2020

BUY
$136.42 - $164.18 $136 - $164
1 Added 0.04%
2,506 $411,000
Q4 2019

Jan 24, 2020

SELL
$106.92 - $132.43 $16,251 - $20,129
-152 Reduced 5.72%
2,505 $329,000
Q2 2019

Jul 12, 2019

BUY
$110.79 - $129.32 $110 - $129
1 Added 0.04%
2,657 $294,000
Q1 2019

May 13, 2019

SELL
$111.31 - $131.02 $27,827 - $32,755
-250 Reduced 8.6%
2,656 $345,000
Q3 2018

Oct 15, 2018

BUY
$85.86 - $107.31 $85 - $107
1 Added 0.03%
2,906 $312,000
Q1 2018

Apr 09, 2018

BUY
$74.21 - $87.6 $74 - $87
1 Added 0.03%
2,905 $225,000
Q4 2017

Jan 12, 2018

SELL
$81.94 - $87.89 $28,597 - $30,673
-349 Reduced 10.73%
2,904 $245,000
Q3 2017

Oct 12, 2017

BUY
$77.07 - $85.54 $250,708 - $278,261
3,253
3,253 $278,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $878B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sheets Smith Wealth Management Portfolio

Follow Sheets Smith Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Sheets Smith Wealth Management with notifications on news.